-
Product Insights
NewLikelihood of Approval Analysis for Cryopyrin-Associated Periodic Syndromes
Overview How likely is it that the drugs in Cryopyrin-Associated Periodic Syndromes will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cryopyrin-Associated Periodic Syndromes Overview cryopyrin-associated periodic syndromes are a group of...
-
Thematic Analysis
NewGlobal Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Sector Analysis
NewPhilippines Renewable Energy Policy Handbook, 2024 Update
"Philippines Renewable Energy Policy Handbook 2024” is among the latest country specific policy reports from GlobalData, the industry analysis specialist. The report offers comprehensive information on major policies governing the renewable energy market in the country and provides information on renewable policies/developments at a regional/municipal level. The report discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of the renewable energy industry. The report also provides major technology specific...
-
Sector Analysis
NewAsia Pacific (APAC) Renewable Energy Policy Handbook, 2024 Update
Asia Pacific (APAC) Renewable Energy Policy Report Overview All Asia Pacific (APAC) countries covered in this report have set targets for renewable energy deployment and generation. A few countries have capacity targets, and a few have generation targets. In the APAC region, feed-in tariff (FiT) has been predominantly the most popular form of incentive utilized to promote renewable power installations. However, competitive bidding or auctions have also gained popularity in the APAC countries to promote renewable energy, especially solar PV,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Canakinumab in Pulmonary Sarcoidosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Canakinumab in Pulmonary Sarcoidosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Canakinumab in Pulmonary Sarcoidosis Drug Details: Canakinumab (Ilaris / Lasprona /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Intracerebral Hemorrhage
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Intracerebral Hemorrhage report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Intracerebral Hemorrhage Drug Details: Anakinra (Kineret) is an immunosuppressant produced...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Canakinumab in Pyoderma Gangrenosum
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Canakinumab in Pyoderma Gangrenosum report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Canakinumab in Pyoderma Gangrenosum Drug Details: Canakinumab (Ilaris / Lasprona / Vyncro)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Canakinumab in Sickle Cell Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Canakinumab in Sickle Cell Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Canakinumab in Sickle Cell Disease Drug Details: Canakinumab (Ilaris / Lasprona...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Cytokine Release Syndrome (Cytokine Storm)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Cytokine Release Syndrome (Cytokine Storm) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Cytokine Release Syndrome (Cytokine Storm) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Mucopolysaccharidosis III (MPS III)...